ALICIA WACHAL: Open Payments
NPI 1073891628 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 25 payments from 10 companies in 2025. Trend: 2023 $715 · 2024 $899 · 2025 $643
Food & beverage: $543Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $190 |
| ABBVIE INC. | 4 | $135 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $107 |
| CooperSurgical, Inc. | 2 | $45 |
| Exeltis, USA Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $20 |
Products named: Veozah, BOTOX, Paragard T 380A, SLYND, MYFEMBREE, LO LOESTRIN FE, LILETTA, Exparel.
Industry payments across NE — which companies pay providers there.
